To date, GWAS in humans have identified 27 CCT-associated loci,
13,16,23–25 and QTL analysis in mice has identified 6 CCT-associated loci. Some of the genes identified in GWAS were independently identified as CCT regulators because of their association with rare connective tissue disorders (i.e., brittle cornea syndrome and osteogenesis imperfecta).
11,12,15 The genes identified by GWAS show an enrichment of pathways involving collagen and extracellular matrix (ECM), which might be expected since the cornea is composed largely of an ECM-rich stroma. Other CCT-influencing genes (e.g.,
Twist2,
Bnc1,
Bcl-2, and
Bax) have been identified through studies that used candidate-driven approaches.
44–46 A comparison of the syntenic regions of
Cctq4 indicated that this locus overlaps partially with
Tiparp, a locus previously reported to be associated with CCT in humans based on a meta-analysis by Lu et al.
16 However,
Tiparp is unlikely to be the gene underlying the association between
Cctq4 and CCT because it (1) does not harbor any protein-affecting DNA base pair changes between the inbred strains we used, and (2) is approximately 37 Mb distant from the SNP with the maximum LOD score.
Cctq5 appears not to overlap with previously identified loci. In the case of
Cctq6, the 95% Bayes credible interval was quite large, spanning ∼60% of the chromosome. Although two previously identified CCT-associated genes (
Fgf9 and
Sgcg) lie within the syntenic interval of
Cctq6, neither of these is likely to be responsible for the association between
Cctq6 and CCT because (1) they are a large distance away from the location with the max LOD score, (2)
Sgcg is not expressed in the mouse cornea, and (3)
Fgf9 in the strains of mice used does not contain any protein-altering DNA base pair changes.